A study on the effect of functional food containing beverage on blood glucose level in human.
- Conditions
- ot applicable
- Registration Number
- JPRN-UMIN000024356
- Lead Sponsor
- Suntory Global Innovation Center Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 21
Not provided
1)Subjects with constant drug treatment. 2)Subjects who are contracting diabetes. 3)Subjects who constantly use supplements and/or functional foods (including Food for Specified Health Uses) affecting the test results. 4)Subjects with a previous history of disease on heart, liver, kidney or digestive organs. 5)Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating. 6)Subjects who drink alcohol a lot and smoke a lot. 7)Subjects who have an irregular sleep cycle, work shift or work on midnight shift. 8)Subjects who have allergic reaction to drug medicine and food. 9)Subjects whose systolic blood pressure is less than 90mmHg. 10)Subjects who donated 200 mL of blood and/or blood components within four weeks prior to the current study. 11)Male subjects whose blood was collected more than 400 mL within the last twelve weeks. 12)Female subjects whose blood was collected more than 400 mL within the last sixteen weeks. 13)Male subjects whose blood was collected more than 1200 mL within the last twelve months when the amount of blood sampling in the current study is added. 14)Female subjects whose blood was collected more than 800 mL within the last twelve months when the amount of blood sampling in the current study is added. 15)Subjects who are participating in other clinical studies for drug medicine or food, or who finished clinical study within four weeks. 16)Subjects who are judged as unsuitable for the study by the principal investigator for other reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Efficacy : Area under the curve of delta blood glucose level. Safety : Incidence of adverse effects
- Secondary Outcome Measures
Name Time Method